Testosterone and Cardiovascular Disease (Traverse Trial)

[madman]

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

*there was no increased risk of prostate cancer between the two groups and no increased risk of lower urinary tract symptoms between the two groups


28:30-29:47

Investigator Reported Adverse Events - statistically significant increase in non-fatal arrhythmias, atrial fibrillation, acute kidney injury)

*again while statistically significant the absolute numbers don't seem that different

 

[madman]

 

[madman]

 

[madman]

LOL!

 

[madman]

 

[madman]

Damn!

 

[madman]

 

[madman]

 

[madman]

 

[madman]